Literature DB >> 1393262

Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum.

M Patel1, C F Spraggs.   

Abstract

1. The gastrin cholecystokinin (CCK) receptors mediating stimulation of acid secretion in rat isolated gastric mucosa (RGM) and contraction in guinea-pig isolated ileum longitudinal muscle-myenteric plexus (GPI) have been characterized by use of peptide agonists and the non-peptide antagonists, lorglumide, devazepide and L-365,260. 2. In RGM, gastrin peptides (sulphated gastrin heptadecapeptide (G-17), non-sulphated (ns) G-17 and pentagastrin) were potent agonists of acid secretion (EC50 values of 4.3, 16 and 27 nM respectively). Sulphated CCK octapeptide (CCK-8) was also a potent agonist, (EC50 = 0.9 nM), but was less efficacious, producing a lower maximal response. In contrast, in GPI, CCK-8 was a potent full agonist (EC50 = 1.4 nM) and was more than 1000 times more potent than the gastrin peptides in producing a sustained contractile response. 3. In GPI, CCK-8 (0.1 to 100 nM) produced sustained contractile responses, whilst CCK-4 (3 to 1000 nM) produced transient responses. These responses had different sensitivities to atropine (1 microM), suggesting that more than one receptor may mediate contraction in this tissue. 4. In RGM, L-365,260 was the most potent antagonist of pentagastrin-stimulated acid secretion (pA2 = 7.6). This functional affinity estimate was similar to that for L-365,260 as an antagonist of excitatory responses in rat ventromedial hypothalamic slices (Kemp et al., 1989) but differed from binding affinity estimates in guinea-pig cortex and gastric glands (Freidinger, 1989). 5. In GPI, devazepide, L-365,260 and lorglumide yielded different affinity estimates when compared against CCK-8 and CCK-4 or pentagastrin respectively.These studies were consistent with the view that the sustained response produced by CCK-8 was mediated by CCKA receptors and the transient response produced by CCK-4 and pentagastrin was mediated by CCKB receptors.6. Affinity estimates for L-365,260 and lorglumide against CCK-4 or pentagastrin in GPI were significantly different from corresponding estimates against pentagastrin in RGM. These studies are consistent with the view that gastrin/CCKB receptors in GPI may differ from those in RGM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393262      PMCID: PMC1907484          DOI: 10.1111/j.1476-5381.1992.tb14328.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  CCK-8, CCK-4 and gastrin-induced contractions in guinea pig ileum: evidence for differential release of acetylcholine and substance P by CCK-A and CCK-B receptors.

Authors:  V L Lucaites; L G Mendelsohn; N R Mason; M L Cohen
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

2.  Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells.

Authors:  R T Jensen; G F Lemp; J D Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

3.  Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation.

Authors:  K Kondo; J A Mitchell; G de Nucci; J R Vane
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

4.  Cholinergic and peptidergic receptors on isolated human antral smooth muscle cells.

Authors:  K N Bitar; B Saffouri; G M Makhlouf
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

5.  Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas.

Authors:  R T Jensen; G F Lemp; J D Gardner
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

6.  Distinct cholecystokinin receptors in brain and pancreas.

Authors:  R B Innis; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

7.  New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity.

Authors:  F Makovec; R Chistè; M Bani; M A Pacini; I Setnikar; L A Rovati
Journal:  Arzneimittelforschung       Date:  1985

8.  A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.

Authors:  V J Lotti; R S Chang
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

Review 9.  Four basic characteristics of the gastrin-cholecystokinin system.

Authors:  J F Rehfeld
Journal:  Am J Physiol       Date:  1981-04

10.  Effect of diadenosine polyphosphates on catecholamine secretion from isolated chromaffin cells.

Authors:  E Castro; M Torres; M T Miras-Portugal; M P Gonzalez
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

View more
  10 in total

1.  Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscle.

Authors:  M F Morton; E A Harper; I A Tavares; N P Shankley
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

2.  Analysis of variation in L-365,260 competition curves in radioligand binding assays.

Authors:  E A Harper; S P Roberts; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

3.  Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.

Authors:  S P Roberts; E A Harper; G F Watt; V P Gerskowitch; R A Hull; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.

Authors:  D M Hills; V P Gerskowitch; S P Roberts; N J Welsh; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

5.  Analysis of the CCKB receptor antagonism of virginiamycin in guinea-pig ileum longitudinal myenteric plexus.

Authors:  M Corsi; G Pojani; G Dal Forno; C Pietra; G Gaviraghi; D Trist
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

6.  Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.

Authors:  S J Boyle; K W Tang; G N Woodruff; A T McKnight
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Nitric oxide, an enteric nonadrenergic-noncholinergic relaxant transmitter: evidence using phosphodiesterase V and nitric oxide synthase inhibition.

Authors:  S J Williams; M E Parsons
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors on gallbladder interstitial cells of Cajal.

Authors:  Dan Xu; Bao-Ping Yu; He-Sheng Luo; Ling-Dan Chen
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

9.  Characterization of the receptors and mechanisms involved in the cardiovascular actions of sCCK-8 in the pithed rat.

Authors:  A J Gaw; D M Hills; C F Spraggs
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

10.  Comparative analysis of the vagal stimulation of gastric acid secretion in rodent isolated stomach preparations.

Authors:  N J Welsh; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.